Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Health Care Facilities & Svcs
  • Sub-Industry: Health Care Services

Psychemedics Corp

+ Add to Watchlist

PMD:US

14.9600 USD 0.0300 0.20%

As of 20:10:00 ET on 01/30/2015.

Snapshot for Psychemedics Corp (PMD)

Open: 15.1700 Day's Range: 14.9500 - 15.1700 Volume: 4,507
Previous Close: 14.9900 52wk Range: 12.4200 - 18.7600 1-Yr Rtn: +1.57%

Stock Chart for PMD

No chart data available.
  • PMD:US 14.9600
  • 1D
  • 1M
  • 1Y
14.9900
Interactive PMD Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PMD

Current P/E Ratio (ttm) 23.7460
Estimated P/E(12/2014) 27.2000
Relative P/E vs. SPX 1.3517
Earnings Per Share (USD) (ttm) 0.6300
Est. EPS (USD) (12/2014) 0.5500
Est. PEG Ratio 1.3600
Market Cap (M USD) 80.41
Shares Outstanding (M) 5.38
30 Day Average Volume 6,460
Price/Book (mrq) 6.2527
Price/Sale (ttm) 2.7623
Dividend Indicated Gross Yield 4.01%
Cash Dividend (USD) 0.1500
Dividend Ex-Date 11/06/2014
5 Year Dividend Growth 0.68%
Next Earnings Announcement 02/10/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PMD

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for PMD

Psychemedics Corporation provides testing services for the detection of abused substances through the analysis of hair samples. The Company's testing methods utilize a patented technology for performing immunoassays on enzymatically dissolved hair samples with confirmation testing by mass spectrometry. Psychemedics screens for the presence of certain drugs of abuse in hair.

Raymond C Kubacki Jr "Ray"Chairman/President/CEONeil L LernerVP:Finance/Treasurer
Sarah AshbyVP/General CounselJames V Dyke "Jim"VP:Sales & Marketing
More Company Profile & Key Executives for PMD

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil